Kathi Niffenegger - 28 Feb 2022 Form 4 Insider Report for Edesa Biotech, Inc. (EDSA)

Role
Chief Financial Officer
Signature
/s/ Kathi Niffenegger
Issuer symbol
EDSA
Transactions as of
28 Feb 2022
Net transactions value
$0
Form type
4
Filing time
07 Mar 2022, 18:40:13 UTC
Next filing
04 Nov 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction EDSA Stock Option (right to buy) Award $0 +43,500 $0.000000 43,500 28 Feb 2022 Common Shares 43,500 $3.71 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This option vests monthly in equal proportions over 36 months beginning on the Grant Date.